Comparative Analysis of Chitosan from Diverse Indian Fishery Wastes: Characterization and in Vitro Physicochemical and Biological Assessment for Pharmaceutical Uses
摘要
Efficient management of fishery waste is vital for sustainability and pollution control, particularly in India, the world’s second-largest fish producer. This study explores the valorization of Indian fishery waste by extracting chitosan, a versatile bioactive polymer with numerous biomedical applications.
MethodsChitosan was derived from chitin extracted from three primary fishery waste sources: rohu fish i.e. (Labeo rohita) scales (RCS), shrimp (Crangon crangon) shells (SCS), and crab (Scylla serrate) shells (CCS) using optimized deacetylation techniques involving 45% NaOH at 90 °C under controlled conditions.
ResultsPhysical characterizations, such as FTIR, XRD, and DSC, confirmed the structural integrity and thermal stability of the chitosan produced. Among the variants, SCS exhibited the highest degree of deacetylation (86.90 ± 0.09%), superior solubility (84.06 ± 0.11%), and enhanced fat-binding capacity (238.06 ± 0.48%), indicating its potential for pharmaceutical applications. SEM analysis revealed a smoother surface morphology and nanofiber arrangement in SCS. Cytotoxicity assays confirmed SCS chitosan’s biocompatibility, with a 96.45 ± 0.21% cell viability in HACAT cell lines. The antifungal efficacy of SCS underscores its promise as a safe, bioactive material for topical pharmaceutical formulations.
ConclusionThis study highlights the sustainability of converting fishery waste into high-value chitosan, aligning with circular economy principles. This approach minimizes ecological impact while fostering resource recovery by transforming fishery waste into a valuable biopolymer. Further clinical validation is necessary to confirm its efficacy and safety for broader applications.